RNAZ Company Profile and Key Details

Q: Who are the executives of RNAZ?

Mr. Thomas A. Fitzgerald M.B.A.Chief Financial Officer, Vice President of Admin. & DirectorDr. Zdravka Medarova Ph.D.Co-Founder, Chief Technology Officer & Member of Advisory BoardDr. Anna Moore Ph.D.Co-Founder, Scientific Advisor & Member of Scientific Advisory BoardSusan DugganSenior Vice President of OperationsMr. Alan FreidmanVice President of Investor & Client RelationsMs. Susan Duggan M.B.A., R.N.Senior Vice President of OperationsDr. Qiyong Peter Liu Ph.D.Vice President of Drug Discovery & Chief ScientistMr. Robert Michael DudleyCo-Founder, Chief Executive Officer, Pres & Director

NASDAQ : RNAZ

TransCode Therapeutics

$8.01

0.08+1.01%

At Close 4:00 PM

66.72

B-ESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

TransCode Therapeutics, Inc. (RNAZ) stock surged +1.01%, trading at $8.01 on NASDAQ, up from the previous close of $7.93. The stock opened at $7.78, fluctuating between $7.59 and $8.02 in the recent session.

Stock Snapshot

7.93

Prev. Close

7.34M

Market Cap

7.59

Day Low

-0.03

P/E Ratio

-236.52

EPS (TTM)

-28.86

Cash Flow per Share

7.78

Open

916.88K

Number of Shares

8.02

Day High

99.85%

Free Float in %

2.62

Book Value

23.87K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jan 09, 2026	7.78	8.14	7.59	8.01	23.93K
Jan 08, 2026	7.09	7.95	7.08	7.93	42.57K
Jan 07, 2026	7.33	7.96	7.26	7.47	61.31K
Jan 06, 2026	7.21	8.20	6.50	7.36	2.26M
Jan 05, 2026	7.04	7.90	7.04	7.31	21.43K
Jan 02, 2026	6.71	7.40	6.71	7.40	20.24K
Dec 31, 2025	6.90	7.33	6.50	6.83	60.37K
Dec 30, 2025	6.62	6.76	6.35	6.44	12.09K
Dec 29, 2025	6.78	6.95	6.08	6.44	20.95K
Dec 26, 2025	7.48	7.48	6.94	6.96	15.43K
Dec 24, 2025	7.15	7.67	7.14	7.43	5.6K
Dec 23, 2025	7.37	7.66	7.32	7.53	20.23K
Dec 22, 2025	8.18	8.43	7.10	7.60	16.44K
Dec 19, 2025	7.61	8.30	7.61	7.92	5.81K
Dec 17, 2025	8.90	9.16	8.26	8.46	14.94K
Dec 16, 2025	9.21	9.31	9.00	9.11	6.97K
Dec 15, 2025	9.56	9.58	8.69	9.07	8.75K
Dec 12, 2025	9.94	10.25	9.28	9.51	16.76K
Dec 11, 2025	9.80	11.28	9.53	10.42	86.51K
Dec 10, 2025	8.35	9.31	8.35	8.63	15.1K

Contact Details

Boston, MA 02109

United States

https://www.transcodetherapeutics.com 857 837 3099

About Company

TransCode Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of drugs and diagnostics for treating and identifying metastatic disease. Its lead therapeutic candidate, TTX-MC138, is a preclinical stage product for the treatment of metastatic cancer. The company's products in preclinical programs include TTX-siPDL1, an siRNA-based modulator of programmed death-ligand 1; TTX-siLIN28B, an siRNA-based inhibitor of RNA-binding protein LIN28B. Its cancer agnostic programs comprise TTX-RIGA, an RNA�based agonist of the RIG-I-driven immune response in the tumor microenvironment; TTX-CRISPR, a CRISPR/Cas9�based therapy platform for the repair or elimination of cancer-causing genes inside tumor cells; and TTX-mRNA, an mRNA-based platform for the development of cancer vaccines meant to activate cytotoxic immune responses against tumor cells. The company was incorporated in 2016 and is based in Boston, Massachusetts.

Stock Peers

REGN

-4.46-0.56%

Regeneron Pharmaceuticals, Inc.$796.55 ARGX

-7.07997-0.89%

argenx SE$788.49 MDGL

-42.16-7.58%

Madrigal Pharmaceuticals, Inc.$514.06 UTHR

-7.6-1.55%

United Therapeutics Corporation$483.23 VRTX

-5.82-1.24%

Vertex Pharmaceuticals Incorporated$463.86 ALNY

-1.11-0.28%

Alnylam Pharmaceuticals, Inc.$398.29 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 PRAX

-5.93-2.01%

Praxis Precision Medicines, Inc.$288.45 KRYS

12.5+5.02%

Krystal Biotech, Inc.$261.41 SGEN

-0.16-0.07%

Seagen Inc.$228.74

Frequently Asked Questions

What is the current TransCode Therapeutics, Inc. (RNAZ) stock price?

TransCode Therapeutics, Inc. (NASDAQ: RNAZ) stock price is $8.01 in the last trading session. During the trading session, RNAZ stock reached the peak price of $8.02 while $7.59 was the lowest point it dropped to. The percentage change in RNAZ stock occurred in the recent session was 1.01% while the dollar amount for the price change in RNAZ stock was $0.08.

RNAZ's industry and sector of operation?

The NASDAQ listed RNAZ is part of Biotechnology industry that operates in the broader Healthcare sector. TransCode Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of RNAZ?

Mr. Thomas A. Fitzgerald M.B.A.
Chief Financial Officer, Vice President of Admin. & Director
Dr. Zdravka Medarova Ph.D.
Co-Founder, Chief Technology Officer & Member of Advisory Board
Dr. Anna Moore Ph.D.
Co-Founder, Scientific Advisor & Member of Scientific Advisory Board
Susan Duggan
Senior Vice President of Operations
Mr. Alan Freidman
Vice President of Investor & Client Relations
Ms. Susan Duggan M.B.A., R.N.
Senior Vice President of Operations
Dr. Qiyong Peter Liu Ph.D.
Vice President of Drug Discovery & Chief Scientist
Mr. Robert Michael Dudley
Co-Founder, Chief Executive Officer, Pres & Director

How RNAZ did perform over past 52-week?

RNAZ's closing price is 31.68% higher than its 52-week low of $6.08 where as its distance from 52-week high of $468.44 is -98.29%.

How many employees does RNAZ have?

Number of RNAZ employees currently stands at 7.

Link for RNAZ official website?

Official Website of RNAZ is: https://www.transcodetherapeutics.com

How do I contact RNAZ?

RNAZ could be contacted at phone 857 837 3099 and can also be accessed through its website. RNAZ operates from 6 Liberty Square, Boston, MA 02109, United States.

How many shares of RNAZ are traded daily?

RNAZ stock volume for the day was 23.87K shares. The average number of RNAZ shares traded daily for last 3 months was 62.95K.

What is the market cap of RNAZ currently?

The market value of RNAZ currently stands at $7.34M with its latest stock price at $8.01 and 916.88K of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	7
Beta	1.53
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	7
Beta	1.53
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

RNAZ Company Profile and Key Details

TransCode Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Earnings & Analyst Outlook

Technical Performance

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Company Overview

Valuation Metrics

Key Takeaways

Price Forecast & Outlook